These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35300816)

  • 1. Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients.
    Friedman DJ; Qin L; Parzynski C; Heist EK; Russo AM; Ranasinghe I; Zeitler EP; Minges KE; Akar JG; Freeman JV; Curtis JP; Al-Khatib SM
    J Am Coll Cardiol; 2022 Mar; 79(11):1050-1059. PubMed ID: 35300816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.
    Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M
    Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.
    Fong KY; Ng CJR; Wang Y; Yeo C; Tan VH
    J Am Heart Assoc; 2022 Jun; 11(11):e024756. PubMed ID: 35656975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction.
    Boersma L; Burke MC; Neuzil P; Lambiase P; Friehling T; Theuns DA; Garcia F; Carter N; Stivland T; Weiss R;
    Heart Rhythm; 2016 Jan; 13(1):157-64. PubMed ID: 26341604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.
    Viani S; Migliore F; Tola G; Pisanò ECL; Russo AD; Luzzi G; Sartori P; Piro A; Rordorf R; Forleo GB; Rago A; Segreti L; Bertaglia E; Biffi M; Lovecchio M; Valsecchi S; Diemberger I; Bongiorni MG
    Heart Rhythm; 2019 Apr; 16(4):564-571. PubMed ID: 30366163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.
    Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM
    Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis.
    Rordorf R; Casula M; Pezza L; Fortuni F; Sanzo A; Savastano S; Vicentini A
    Heart Rhythm; 2021 Mar; 18(3):382-391. PubMed ID: 33212250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
    JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device-related infection associated with increased mortality risk in de novo transvenous implantable cardioverter-defibrillator medicare patients.
    El-Chami MF; Liu Y; Griffiths RI; Knight BP; Weiss R; Mark GE; Biffi M; Probst V; Lambiase PD; Miller MA; Jacobsen CM; Baddour LM
    J Cardiovasc Electrophysiol; 2022 Apr; 33(4):725-730. PubMed ID: 35066954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
    Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
    Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.
    Vetta G; Parlavecchio A; Magnocavallo M; Valente D; Caminiti R; Polselli M; Vetta F; Cirone D; Cauti FM; Crea P; Rossi P; Chierchia GB; Bianchi S; de Asmundis C; Natale A; Della Rocca DG
    Pacing Clin Electrophysiol; 2022 Dec; 45(12):1409-1414. PubMed ID: 36214206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current clinical practice of subcutaneous implantable cardioverter-defibrillator: Analysis using the JROAD-DPC database.
    Tonegawa-Kuji R; Inoue YY; Nakai M; Kanaoka K; Sumita Y; Miyazaki Y; Wakamiya A; Shimamoto K; Ueda N; Wada M; Yamagata K; Ishibashi K; Miyamoto K; Nagase S; Aiba T; Iwanaga Y; Miyamoto Y; Kusano K
    Heart Rhythm; 2022 Jun; 19(6):909-916. PubMed ID: 35158088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
    Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
    Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Assessment of Transvenous versus Subcutaneous Implantable Cardioverter-defibrillator Therapy Outcomes: An Updated Systematic Review and Meta-analysis.
    Nso N; Nassar M; Lakhdar S; Enoru S; Guzman L; Rizzo V; Munira MS; Radparvar F; Thambidorai S
    Int J Cardiol; 2022 Feb; 349():62-78. PubMed ID: 34801615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
    Gold MR; El-Chami MF; Burke MC; Upadhyay GA; Niebauer MJ; Prutkin JM; Herre JM; Kutalek S; Dinerman JL; Knight BP; Leigh J; Lucas L; Carter N; Brisben AJ; Aasbo JD; Weiss R;
    J Am Coll Cardiol; 2023 Aug; 82(5):383-397. PubMed ID: 37495274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.